NTN Swiss Biotech – A Look at Support Measures for Dynamic Start-ups
Keywords:Ntn swiss biotech, Red biotechnology, Start-up
AbstractThe Swiss biotech landscape seems to be on a healthy footing: There are many imaginative start-ups, we have first-class hospitals, highly advanced clinical research and the availability of a great deal of capital. But we have no reason to rest on our laurels as countries like the USA lead the field. We must lay down the tracks today to remain an attractive country and maintain our ranking among the 10 best locations.
How to Cite
E. Heinzelmann, Chimia 2016, 70, 121, DOI: 10.2533/chimia.2016.121.
Columns, Conference Reports
Copyright (c) 2016 Swiss Chemical Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.